Dr David van der Poorten

Clinical Senior Lecturer
Medicine, Westmead Clinical School

Telephone 9845 5687
Fax 9687 2183

Map

Selected publications

Download citations: PDF RTF Endnote

Book Chapters

  • van der Poorten, D., Milner, K., George, J. (2009). Effect of adipokines on liver disease in females. In Ichiro Shimizu (Eds.), Female Hepatology: Impact of female sex against progression of liver disease, (pp. 191-212). India: Research Signpost.

Journals

  • Sivagnanam, S., van der Poorten, D., Douglas, M. (2014). Hepatic lesions and eosinophilia in an urban dweller. Liver International, 34(4), 643-643. [More Information]
  • O'Connor, K., Parnell, G., Patrick, E., Ahlenstiel, G., Suppiah, V., van der Poorten, D., Read, S., Leung, R., Douglas, M., Yang, J., Stewart, G., Liddle, C., George, J., Booth, D. (2014). Hepatic metallothionein expression in chronic hepatitis C virus infection is IFNL3 genotype-dependent. Genes and Immunity, 15(2), 88-94. [More Information]
  • O'Connor, K., Ahlenstiel, G., Suppiah, V., Schibeci, S., Ong, A., Leung, R., van der Poorten, D., Douglas, M., Weltman, M., Stewart, G., Liddle, C., George, J., Booth, D. (2014). IFNL3 mediates interaction between innate immune cells: Implications for hepatitis C virus pathogenesis. Innate Immunity, 20(6), 598-605. [More Information]
  • van der Poorten, D., Samer, C., Ramezani-Moghadam, M., Coulter, S., Kacevska, M., Schrijnders, D., Wu, L., McLeod, D., Bugianesi, E., Komuta, M., Liddle, C., Hebbard, L., George, J., et al (2013). Hepatic Fat Loss in Advanced Nonalcoholic Steatohepatitis: Are Alterations in Serum Adiponectin the Cause? Hepatology, 57(6), 2180-2188. [More Information]
  • Vongsuvanh, R., van der Poorten, D., George, J. (2013). Non-alcoholic fatty liver disease-related hepatocellular carcinoma: a sleeping tiger in the Asia Pacific. Hepatology International, 7(Suppl 2), S823-S832. [More Information]
  • Hashemi, S., van der Poorten, D., Barrera Martinez, F., Bandara, P., Lux, O., Kench, J., George, J. (2013). Oxidative stress is closely associated with insulin resistance in genotypes 1 and 3 chronic hepatitis C. Hepatology International, 7(2), 516-523. [More Information]
  • Vongsuvanh, R., George, J., Qiao, L., van der Poorten, D. (2013). Visceral adiposity in gastrointestinal and hepatic carcinogenesis. Cancer Letters, 330(1), 1-10. [More Information]
  • Nguyen, V., George, J., van der Poorten, D. (2012). A maxillary mass in a HBV-cirrhotic patient. Liver International, 32(6), 988-988. [More Information]
  • Vongsuvanh, R., George, J., McLeod, D., van der Poorten, D. (2012). Visceral adiposity index is not a predictor of liver histology in patients with non-alcoholic fatty liver disease. Journal of Hepatology, 57(2), 392-398. [More Information]
  • Adams, L., George, J., Bugianesi, E., Rossi, E., de Boer, W., van der Poorten, D., Ching, H., Bulsara, M., Jeffrey, G. (2011). Complex non-invasive fibrosis models are more accurate than simple models in non-alcoholic fatty liver disease. Journal of Gastroenterology and Hepatology, 26(10), 1536-1543. [More Information]
  • Nguyen, V., Gurney, H., van der Poorten, D. (2011). Paraneoplastic Hepatic Dysfunction in Metastatic Prostate Cancer: The Role of Cytokine Dysregulation. Journal of Clinical Oncology, 29(2), e21-e23. [More Information]
  • Bhala, N., Angulo, P., van der Poorten, D., Lee, E., Hui, J., Saracco, G., Adams, L., Charatcharoenwitthaya, P., Topping, J., Bugianesi, E., George, J., et al (2011). The natural history of nonalcoholic fatty liver disease with advanced fibrosis or cirrhosis: An international collaborative study. Hepatology, 54(4), 1208-1216. [More Information]
  • Milner, K., van der Poorten, D., Trenell, M., Jenkins, A., Xu, A., Smythe, G., Dore, G., Zekry, A., Weltman, M., Fragomeli, V., George, J., et al (2010). Chronic Hepatitis C is Associated with Peripheral rather than Hepatic Insulin Resistance. Gastroenterology, 138(3), 932-941. [More Information]
  • van der Poorten, D., Shahidi, M., Tay, E., Sesha, J., Tran, K., McLeod, D., Milliken, J., Ho, V., Hebbard, L., Douglas, M., George, J. (2010). Hepatitis C Virus Induces the Cannabinoid Receptor 1. PloS One, 5(9), 1-10. [More Information]
  • Milner, K., van der Poorten, D., Xu, A., Bugianesi, E., Kench, J., Lam, K., Chisholm, D., George, J. (2009). Adipocyte fatty acid binding protein levels relate to inflammation and fibrosis in nonalcoholic fatty liver disease. Hepatology, 49(6), 1926-1934. [More Information]
  • van der Poorten, D., George, J. (2008). Disease-specific mechanisms of fibrosis: hepatitis C virus and nonalcoholic steatohepatitis. Clinics in Liver Disease, 12(4), 805-824. [More Information]
  • van der Poorten, D., George, J. (2008). Nonalcoholic steatohepatitis is frequently acompanied by metabolic diseases: Reply to the Editor. Hepatology, 48(5), 1729. [More Information]
  • van der Poorten, D., Kenny, D., George, J. (2008). Prevalence of and risk factors for hepatitis C in Aboriginal and non-Aboriginal adolescent offenders. Medical Journal of Australia, 188(10), 610-614. [More Information]
  • van der Poorten, D., Milner, K., Hui, J., Hodge, A., Trenell, M., Kench, J., London, R., Peduto, A., Chisholm, D., George, J. (2008). Visceral fat: A key mediator of steatohepatitis in metabolic liver disease. Hepatology, 48(2), 449-457. [More Information]
  • van der Poorten, D., Kenny, D., George, J. (2007). A new upper limit for alanine aminotransferase and risk factors for raised alt and hepatitis C in adolescents: a study of 439 male adolescent offenders on community orders. Journal of Gastroenterology and Hepatology, 22(Supplement 3), A344-A344.
  • van der Poorten, D., Prakoso, E., Khoo, T., Ngu, M., McCaughan, G., Strasser, S., Lee, A. (2007). Combination adefovir-lamivudine prevents emergence of adefovir resistance in lamivudine-resistant hepatitis B. Journal of Gastroenterology and Hepatology, 22(9), 1500-1505. [More Information]
  • van der Poorten, D., George, J. (2007). Current and novel therapies for the treatment of nonalcoholic steatohepatitis. Hepatology International, 1(3), 343-354. [More Information]
  • van der Poorten, D., Kenny, D., Butler, T., George, J. (2007). Liver disease in adolescents: A cohort study of high-risk individuals. Hepatology, 46(6), 1750-1758. [More Information]
  • van der Poorten, D., Katelaris, P. (2007). The effectiveness of rifabutin triple therapy for difficult-to-eradicate Helicobacter pylori in clinical practice. Alimentary Pharmacology and Therapeutics, 26(11), 1537-1542. [More Information]
  • van der Poorten, D., Kwok, A., Lam, T., Ridley, L., Jones, B., Ngu, M., Lee, A. (2006). Twenty-year audit of percutaneous liver biopsy in a major Australian teaching hospital. Internal Medicine Journal, 36(11), 692-699. [More Information]

Conferences

  • van der Poorten, D., Kenny, D. (2007). Young offenders in custody and the community: Similarities and differences. 3rd International Congress of Psychology and Law, in conjunction with the 27th Annual Congress of ANZAPPL.

2014

  • Sivagnanam, S., van der Poorten, D., Douglas, M. (2014). Hepatic lesions and eosinophilia in an urban dweller. Liver International, 34(4), 643-643. [More Information]
  • O'Connor, K., Parnell, G., Patrick, E., Ahlenstiel, G., Suppiah, V., van der Poorten, D., Read, S., Leung, R., Douglas, M., Yang, J., Stewart, G., Liddle, C., George, J., Booth, D. (2014). Hepatic metallothionein expression in chronic hepatitis C virus infection is IFNL3 genotype-dependent. Genes and Immunity, 15(2), 88-94. [More Information]
  • O'Connor, K., Ahlenstiel, G., Suppiah, V., Schibeci, S., Ong, A., Leung, R., van der Poorten, D., Douglas, M., Weltman, M., Stewart, G., Liddle, C., George, J., Booth, D. (2014). IFNL3 mediates interaction between innate immune cells: Implications for hepatitis C virus pathogenesis. Innate Immunity, 20(6), 598-605. [More Information]

2013

  • van der Poorten, D., Samer, C., Ramezani-Moghadam, M., Coulter, S., Kacevska, M., Schrijnders, D., Wu, L., McLeod, D., Bugianesi, E., Komuta, M., Liddle, C., Hebbard, L., George, J., et al (2013). Hepatic Fat Loss in Advanced Nonalcoholic Steatohepatitis: Are Alterations in Serum Adiponectin the Cause? Hepatology, 57(6), 2180-2188. [More Information]
  • Vongsuvanh, R., van der Poorten, D., George, J. (2013). Non-alcoholic fatty liver disease-related hepatocellular carcinoma: a sleeping tiger in the Asia Pacific. Hepatology International, 7(Suppl 2), S823-S832. [More Information]
  • Hashemi, S., van der Poorten, D., Barrera Martinez, F., Bandara, P., Lux, O., Kench, J., George, J. (2013). Oxidative stress is closely associated with insulin resistance in genotypes 1 and 3 chronic hepatitis C. Hepatology International, 7(2), 516-523. [More Information]
  • Vongsuvanh, R., George, J., Qiao, L., van der Poorten, D. (2013). Visceral adiposity in gastrointestinal and hepatic carcinogenesis. Cancer Letters, 330(1), 1-10. [More Information]

2012

  • Nguyen, V., George, J., van der Poorten, D. (2012). A maxillary mass in a HBV-cirrhotic patient. Liver International, 32(6), 988-988. [More Information]
  • Vongsuvanh, R., George, J., McLeod, D., van der Poorten, D. (2012). Visceral adiposity index is not a predictor of liver histology in patients with non-alcoholic fatty liver disease. Journal of Hepatology, 57(2), 392-398. [More Information]

2011

  • Adams, L., George, J., Bugianesi, E., Rossi, E., de Boer, W., van der Poorten, D., Ching, H., Bulsara, M., Jeffrey, G. (2011). Complex non-invasive fibrosis models are more accurate than simple models in non-alcoholic fatty liver disease. Journal of Gastroenterology and Hepatology, 26(10), 1536-1543. [More Information]
  • Nguyen, V., Gurney, H., van der Poorten, D. (2011). Paraneoplastic Hepatic Dysfunction in Metastatic Prostate Cancer: The Role of Cytokine Dysregulation. Journal of Clinical Oncology, 29(2), e21-e23. [More Information]
  • Bhala, N., Angulo, P., van der Poorten, D., Lee, E., Hui, J., Saracco, G., Adams, L., Charatcharoenwitthaya, P., Topping, J., Bugianesi, E., George, J., et al (2011). The natural history of nonalcoholic fatty liver disease with advanced fibrosis or cirrhosis: An international collaborative study. Hepatology, 54(4), 1208-1216. [More Information]

2010

  • Milner, K., van der Poorten, D., Trenell, M., Jenkins, A., Xu, A., Smythe, G., Dore, G., Zekry, A., Weltman, M., Fragomeli, V., George, J., et al (2010). Chronic Hepatitis C is Associated with Peripheral rather than Hepatic Insulin Resistance. Gastroenterology, 138(3), 932-941. [More Information]
  • van der Poorten, D., Shahidi, M., Tay, E., Sesha, J., Tran, K., McLeod, D., Milliken, J., Ho, V., Hebbard, L., Douglas, M., George, J. (2010). Hepatitis C Virus Induces the Cannabinoid Receptor 1. PloS One, 5(9), 1-10. [More Information]

2009

  • Milner, K., van der Poorten, D., Xu, A., Bugianesi, E., Kench, J., Lam, K., Chisholm, D., George, J. (2009). Adipocyte fatty acid binding protein levels relate to inflammation and fibrosis in nonalcoholic fatty liver disease. Hepatology, 49(6), 1926-1934. [More Information]
  • van der Poorten, D., Milner, K., George, J. (2009). Effect of adipokines on liver disease in females. In Ichiro Shimizu (Eds.), Female Hepatology: Impact of female sex against progression of liver disease, (pp. 191-212). India: Research Signpost.

2008

  • van der Poorten, D., George, J. (2008). Disease-specific mechanisms of fibrosis: hepatitis C virus and nonalcoholic steatohepatitis. Clinics in Liver Disease, 12(4), 805-824. [More Information]
  • van der Poorten, D., George, J. (2008). Nonalcoholic steatohepatitis is frequently acompanied by metabolic diseases: Reply to the Editor. Hepatology, 48(5), 1729. [More Information]
  • van der Poorten, D., Kenny, D., George, J. (2008). Prevalence of and risk factors for hepatitis C in Aboriginal and non-Aboriginal adolescent offenders. Medical Journal of Australia, 188(10), 610-614. [More Information]
  • van der Poorten, D., Milner, K., Hui, J., Hodge, A., Trenell, M., Kench, J., London, R., Peduto, A., Chisholm, D., George, J. (2008). Visceral fat: A key mediator of steatohepatitis in metabolic liver disease. Hepatology, 48(2), 449-457. [More Information]

2007

  • van der Poorten, D., Kenny, D., George, J. (2007). A new upper limit for alanine aminotransferase and risk factors for raised alt and hepatitis C in adolescents: a study of 439 male adolescent offenders on community orders. Journal of Gastroenterology and Hepatology, 22(Supplement 3), A344-A344.
  • van der Poorten, D., Prakoso, E., Khoo, T., Ngu, M., McCaughan, G., Strasser, S., Lee, A. (2007). Combination adefovir-lamivudine prevents emergence of adefovir resistance in lamivudine-resistant hepatitis B. Journal of Gastroenterology and Hepatology, 22(9), 1500-1505. [More Information]
  • van der Poorten, D., George, J. (2007). Current and novel therapies for the treatment of nonalcoholic steatohepatitis. Hepatology International, 1(3), 343-354. [More Information]
  • van der Poorten, D., Kenny, D., Butler, T., George, J. (2007). Liver disease in adolescents: A cohort study of high-risk individuals. Hepatology, 46(6), 1750-1758. [More Information]
  • van der Poorten, D., Katelaris, P. (2007). The effectiveness of rifabutin triple therapy for difficult-to-eradicate Helicobacter pylori in clinical practice. Alimentary Pharmacology and Therapeutics, 26(11), 1537-1542. [More Information]
  • van der Poorten, D., Kenny, D. (2007). Young offenders in custody and the community: Similarities and differences. 3rd International Congress of Psychology and Law, in conjunction with the 27th Annual Congress of ANZAPPL.

2006

  • van der Poorten, D., Kwok, A., Lam, T., Ridley, L., Jones, B., Ngu, M., Lee, A. (2006). Twenty-year audit of percutaneous liver biopsy in a major Australian teaching hospital. Internal Medicine Journal, 36(11), 692-699. [More Information]

To update your profile click here. For support on your academic profile contact .